Holly Daquana, NP | |
1990 Industrial Boulevard, Houma, LA 70363-7055 | |
(985) 868-9300 | |
(985) 851-0053 |
Full Name | Holly Daquana |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 22 Years |
Location | 1990 Industrial Boulevard, Houma, Louisiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063458966 | NPI | - | NPPES |
1169897 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | AP04301 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ochsner Home Health Of Raceland | Raceland, LA | Home health agency |
Leonard J Chabert Medical Center | Houma, LA | Hospital |
Ochsner Clinic Foundation | New orleans, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
South Louisiana Medical Associates | 8527968650 | 107 |
News Archive
"Pharmaceutical companies, once blasted as uncaring or downright greedy for charging thousands of dollars for a year's worth of AIDS medicines … in poor countries, lately have been slashing prices and licensing their drugs for free or nominal cost to nonprofits or local manufacturers in the developing world," Bloomberg BusinessWeek writes in an analysis piece that examines how this trend, combined with a growing capability among aid agencies to distribute drugs, has the potential to increase access to HIV/AIDS drugs worldwide.
The University of Illinois Hospital is the first center in North America to prescribe a new FDA-approved treatment for patients with the most common and aggressive type of brain tumor, glioblastoma multiforme, or GBM.
Celsion Corporation, a leading oncology drug development company, today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on the application for Orphan Drug Designation for ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, for the treatment of hepatocellular carcinoma (HCC), commonly referred to as primary liver cancer.
Minor physical anomalies are more common in schizophrenia patients and their unaffected siblings than in mentally healthy individuals without a family history of the disorder, research shows.
A new study published in March 2020 in the journal Nature Medicine reports the use of a wireless system of skin-mounted sensors to monitor the health of newborn babies in an inexpensive and versatile platform that can be adapted to the vast majority of healthcare settings with ease.
› Verified 3 days ago
Entity Name | South Louisiana Medical Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942301379 PECOS PAC ID: 8527968650 Enrollment ID: O20040113000589 |
News Archive
"Pharmaceutical companies, once blasted as uncaring or downright greedy for charging thousands of dollars for a year's worth of AIDS medicines … in poor countries, lately have been slashing prices and licensing their drugs for free or nominal cost to nonprofits or local manufacturers in the developing world," Bloomberg BusinessWeek writes in an analysis piece that examines how this trend, combined with a growing capability among aid agencies to distribute drugs, has the potential to increase access to HIV/AIDS drugs worldwide.
The University of Illinois Hospital is the first center in North America to prescribe a new FDA-approved treatment for patients with the most common and aggressive type of brain tumor, glioblastoma multiforme, or GBM.
Celsion Corporation, a leading oncology drug development company, today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on the application for Orphan Drug Designation for ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, for the treatment of hepatocellular carcinoma (HCC), commonly referred to as primary liver cancer.
Minor physical anomalies are more common in schizophrenia patients and their unaffected siblings than in mentally healthy individuals without a family history of the disorder, research shows.
A new study published in March 2020 in the journal Nature Medicine reports the use of a wireless system of skin-mounted sensors to monitor the health of newborn babies in an inexpensive and versatile platform that can be adapted to the vast majority of healthcare settings with ease.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Holly Daquana, NP 1990 Industrial Boulevard, Houma, LA 70363-7055 Ph: (985) 868-9300 | Holly Daquana, NP 1990 Industrial Boulevard, Houma, LA 70363-7055 Ph: (985) 868-9300 |
News Archive
"Pharmaceutical companies, once blasted as uncaring or downright greedy for charging thousands of dollars for a year's worth of AIDS medicines … in poor countries, lately have been slashing prices and licensing their drugs for free or nominal cost to nonprofits or local manufacturers in the developing world," Bloomberg BusinessWeek writes in an analysis piece that examines how this trend, combined with a growing capability among aid agencies to distribute drugs, has the potential to increase access to HIV/AIDS drugs worldwide.
The University of Illinois Hospital is the first center in North America to prescribe a new FDA-approved treatment for patients with the most common and aggressive type of brain tumor, glioblastoma multiforme, or GBM.
Celsion Corporation, a leading oncology drug development company, today announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has issued a positive opinion on the application for Orphan Drug Designation for ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, for the treatment of hepatocellular carcinoma (HCC), commonly referred to as primary liver cancer.
Minor physical anomalies are more common in schizophrenia patients and their unaffected siblings than in mentally healthy individuals without a family history of the disorder, research shows.
A new study published in March 2020 in the journal Nature Medicine reports the use of a wireless system of skin-mounted sensors to monitor the health of newborn babies in an inexpensive and versatile platform that can be adapted to the vast majority of healthcare settings with ease.
› Verified 3 days ago
Christy L Hebert, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8120 Main St Ste 301, Houma, LA 70360 Phone: 985-851-6653 Fax: 985-872-1420 | |
Mr. Philip Andrew Lottinger Jr., PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 235 Civic Center Blvd, Houma, LA 70360 Phone: 985-851-0162 | |
Caroline Hebert, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1297 Saint Charles St Ste H, Houma, LA 70360 Phone: 985-665-1020 | |
Deeanna Bennett Beaver, APRN, NP. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 165 Corporate Drive, Houma, LA 70360 Phone: 985-851-1001 Fax: 985-851-1017 | |
Laina Leboeuf, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 153 Aubrey Drive, Houma, LA 70360 Phone: 985-868-7786 Fax: 985-868-7786 | |
Shawn M Keller, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 235 Civic Center Blvd, Houma, LA 70360 Phone: 225-333-2020 | |
Virginia M Pellegrin, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 509 Dunn St, Houma, LA 70360 Phone: 985-876-1714 Fax: 985-868-6549 |